Sylvester Comprehensive Cancer Center


Tumor-cell infiltration into the liver of a TET2-ko mouse.

Studying a Catalyst for Blood Cancers


Mingjiang Xu, M.D., Ph.D., cancer researcher at Sylvester Comprehensive Cancer Center, and colleagues have been studying the protein TET2, a tumor suppressor, for several years. They recently published a paper in the prestigious journal Nature Communications, which describes how TET2 loss can open the door for mutations that drive myeloid, lymphoid, and other cancers.